Orchid Pharma Sees Surge in Trading Activity Amid Sector Gains
2025-04-03 11:00:17Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant trading activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 833.55, reflecting a notable increase of 4.99% from its previous levels. The last traded price stood at Rs 803.55, marking an absolute change of 9.65 and a percentage change of 1.22%. Today's trading saw a total volume of approximately 1.03 million shares, resulting in a turnover of around Rs 8.50 crore. The stock opened with a gain of 2.03%, indicating positive momentum from the start of the trading session. Over the past three days, Orchid Pharma has shown a cumulative return of 4.37%, although it has underperformed its sector by 0.43% today. In terms of liquidity, the stock has demonstrated sufficient trading activity, with a delivery volume of 68,670 shares, which is an increase of 8.74% compared to th...
Read More
Orchid Pharma Faces Financial Struggles Amid Significant Stock Volatility and Underperformance
2025-04-02 10:06:08Orchid Pharma has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company reported a significant decline in profit and has a concerning financial outlook, characterized by low Return on Equity and a weak EBIT to Interest ratio. Its stock remains highly valued compared to peers.
Read MoreOrchid Pharma Stock Surges Amidst Market Challenges, Reflecting Investor Interest
2025-03-28 12:00:07Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown significant activity today as its stock hit the upper circuit limit. The stock reached an intraday high of Rs 815.95, reflecting a 5% increase from its previous trading session. This surge comes amidst a total traded volume of approximately 0.35126 lakh shares, resulting in a turnover of Rs 2.82 crore. Despite the positive movement, Orchid Pharma's last traded price stands at Rs 800.60, which is still lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock has outperformed its sector by 3.22%, while the broader market, represented by the Sensex, has seen a slight decline of 0.07%. Notably, Orchid Pharma is currently 4.9% away from its 52-week low of Rs 761.10, indicating a resilient performance in the face of market fluctuations. The delivery volume has shown a slight decrease compared to...
Read More
Orchid Pharma Hits 52-Week Low Amid Broader Market Recovery and Financial Concerns
2025-03-27 12:06:51Orchid Pharma has hit a new 52-week low, continuing a downward trend with a significant decline over the past three days. The company's annual performance has been poor, with a notable drop in profits and a low return on equity, raising concerns about its financial stability and debt servicing capabilities.
Read More
Orchid Pharma Faces Continued Volatility Amid Weak Financial Performance and Bearish Sentiment
2025-03-26 09:42:05Orchid Pharma has faced significant volatility, reaching a new 52-week low amid a continued downward trend. The stock has underperformed its sector and recorded a notable decline over the past year. Despite high institutional ownership, the company's fundamentals and recent financial results indicate a weak outlook.
Read More
Orchid Pharma Faces Significant Volatility Amidst Weak Financial Performance and Market Sentiment
2025-03-25 10:06:09Orchid Pharma has faced notable volatility, reaching a 52-week low and underperforming its sector. The company reported a significant decline in profit and has concerning financial metrics, including low ROE and a poor EBIT to Interest ratio. Despite a slight increase in institutional holdings, market sentiment remains cautious.
Read MoreOrchid Pharma Experiences Notable Stock Surge Amid Positive Market Dynamics
2025-03-24 12:00:07Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown significant activity today as it hit its upper circuit limit. The stock reached an intraday high of Rs 866.45, reflecting a 5% increase from its previous trading session. This surge comes after a two-day decline, marking a notable trend reversal for the company. The stock's last traded price (LTP) stands at Rs 848.55, with a change of Rs 23.35, or a 2.83% increase. Orchid Pharma's performance today outpaced its sector by 2.61%, indicating a strong rebound in investor sentiment. The total traded volume reached approximately 0.65936 lakh shares, contributing to a turnover of Rs 5.64 crore. In terms of moving averages, the stock is currently above its 5-day moving average but remains below the 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a rise in delivery volume, which increased by 7.52% c...
Read MoreOrchid Pharma's Stock Hits Upper Circuit, Signaling Strong Market Position and Activity
2025-03-19 11:00:12Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has made headlines today as its stock hit the upper circuit limit, reaching an intraday high of Rs 874.85. This marks a significant achievement for the company, reflecting a change of Rs 22.3 or 2.68% from the previous close. The stock's performance today has outpaced its sector by 2.69%, showcasing its strong market position. Throughout the trading session, Orchid Pharma recorded a total traded volume of approximately 0.85232 lakh shares, resulting in a turnover of Rs 7.34 crore. The stock's last traded price stood at Rs 855.5, with a notable low of Rs 833.2 during the day. Despite a decline in delivery volume, which fell by 28.88% against the five-day average, the stock has shown resilience, gaining 8.57% over the last three days. In terms of moving averages, Orchid Pharma's stock is currently above its five-day moving averag...
Read MoreOrchid Pharma Sees Surge in Trading Activity Amid Increased Investor Participation
2025-03-18 13:00:08Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 846.4, reflecting a 5% increase from its previous trading session. The last traded price stood at Rs 819.9, marking a change of Rs 13.8 or 1.71%. Today's trading saw a total volume of approximately 0.90514 lakh shares, resulting in a turnover of Rs 7.48 crore. Notably, Orchid Pharma has outperformed its sector by 0.65% and has recorded consecutive gains over the past two days, accumulating a total return of 3.96% during this period. Despite trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock has experienced a notable increase in investor participation, with delivery volume rising by 119.23% compared to the 5-day average. In summary, Orchid Pharma's performance today highli...
Read MoreAnnouncement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
09-Apr-2025 | Source : BSEIntimation for entering into a Joint Memo of Compromise with DBS Bank India Limited under Regulation 30 of SEBI Listing Regulations.
Intimation Of Letter(S)/Emails Received From Stock Exchanges As Cautionary Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-Mar-2025 | Source : BSEIntimation of Letters/emails received from Stock Exchanges as Cautionary under SEBI Listing Regulations 2015.
Closure of Trading Window
27-Mar-2025 | Source : BSEIntimation of the Trading Window Closure for the Quarter IV and Financial Year ending on March 31 2025
Corporate Actions
No Upcoming Board Meetings
Orchid Pharma Ltd has declared 30% dividend, ex-date: 13 Sep 12
No Splits history available
No Bonus history available
No Rights history available